Dempze Nancy E Abbott Laboratories Transaction History

Dempze Nancy E

$158 Million
Q2 2025

A detailed history of Dempze Nancy E transactions in Abbott Laboratories stock. As of the latest transaction made, Dempze Nancy E holds 42,308 shares of ABT stock, worth $5.42 Million. This represents 3.63% of its overall portfolio holdings.

Number of Shares

42,308

Previous 42,662 0.83%

Holding current value

$5.42 Million

Previous $5.66 Million 1.68%

% of portfolio

3.63%

Previous 3.74%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 23, 2025	SELL	$123.95 - $138.08 $43,878 - $48,880	-354 Reduced 0.83%	42,308 $5.75 Million
Q1 2025 May 06, 2025	BUY	$111.1 - $140.22 $109,433 - $138,116	985 Added 2.36%	42,662 $5.66 Million
Q4 2024 Feb 12, 2025	BUY	$111.93 - $119.39 $208,749 - $222,662	1,865 Added 4.68%	41,677 $4.71 Million
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $236,665 - $279,377	2,365 Added 6.32%	39,812 $4.54 Million
Q2 2024 Aug 12, 2024	BUY	$100.73 - $112.44 $89,649 - $100,071	890 Added 2.43%	37,447 $3.89 Million
Q1 2024 May 13, 2024	BUY	$109.52 - $120.96 $91,120 - $100,638	832 Added 2.33%	36,557 $4.16 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $126,716 - $155,112	1,405 Added 4.09%	35,725 $3.93 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $66,584 - $79,890	697 Added 2.07%	34,320 $3.32 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $109,043 - $121,497	1,082 Added 3.33%	33,623 $3.67 Million
Q1 2023 May 10, 2023	BUY	$96.86 - $114.01 $58,794 - $69,204	607 Added 1.9%	32,541 $3.3 Million
Q4 2022 Feb 09, 2023	BUY	$95.06 - $111.52 $120,155 - $140,961	1,264 Added 4.12%	31,934 $3.51 Million
Q3 2022 Nov 08, 2022	BUY	$96.76 - $112.03 $193 - $224	2 Added 0.01%	30,670 $2.97 Million
Q2 2022 Jul 19, 2022	SELL	$102.07 - $123.37 $476,768 - $576,261	-4,671 Reduced 13.22%	30,668 $3.33 Million
Q1 2022 May 17, 2022	SELL	$114.02 - $139.04 $3,990 - $4,866	-35 Reduced 0.1%	35,339 $4.18 Million
Q4 2021 Feb 08, 2022	BUY	$115.53 - $141.46 $103,630 - $126,889	897 Added 2.6%	35,374 $4.98 Million
Q3 2021 Nov 10, 2021	SELL	$116.66 - $129.06 $9,332 - $10,324	-80 Reduced 0.23%	34,477 $4.07 Million
Q2 2021 Aug 09, 2021	SELL	$105.79 - $124.53 $400,415 - $471,346	-3,785 Reduced 9.87%	34,557 $4.01 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $124,077 - $146,182	-1,140 Reduced 2.89%	38,342 $4.6 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $138,075 - $150,462	-1,315 Reduced 3.22%	39,482 $4.32 Million
Q3 2020 Oct 28, 2020	BUY	$91.64 - $111.29 $224,518 - $272,660	2,450 Added 6.39%	40,797 $4.44 Million
Q2 2020 Jul 28, 2020	SELL	$76.57 - $98.0 $70,061 - $89,670	-915 Reduced 2.33%	38,347 $3.51 Million
Q1 2020 May 07, 2020	SELL	$62.82 - $91.86 $42,717 - $62,464	-680 Reduced 1.7%	39,262 $3.1 Million
Q4 2019 Jan 15, 2020	BUY	$78.51 - $87.4 $43,023 - $47,895	548 Added 1.39%	39,942 $3.47 Million
Q3 2019 Nov 07, 2019	SELL	$81.84 - $88.74 $363,451 - $394,094	-4,441 Reduced 10.13%	39,394 $3.3 Million
Q2 2019 Jul 24, 2019	SELL	$72.88 - $85.0 $89,350 - $104,210	-1,226 Reduced 2.72%	43,835 $3.69 Million
Q1 2019 May 01, 2019	SELL	$66.22 - $80.06 $36,685 - $44,353	-554 Reduced 1.21%	45,061 $3.6 Million
Q4 2018 Jan 24, 2019	SELL	$65.56 - $74.27 $116,893 - $132,423	-1,783 Reduced 3.76%	45,615 $3.3 Million
Q3 2018 Oct 15, 2018	SELL	$60.81 - $73.36 $1,581 - $1,907	-26 Reduced 0.05%	47,398 $3.48 Million
Q2 2018 Jul 30, 2018	SELL	$57.57 - $63.54 $25,273 - $27,894	-439 Reduced 0.92%	47,424 $2.89 Million
Q1 2018 Apr 24, 2018	BUY	$56.27 - $63.62 $19,525 - $22,076	347 Added 0.73%	47,863 $2.87 Million
Q4 2017 Feb 02, 2018	BUY	$53.68 - $57.47 $422,998 - $452,863	7,880 Added 19.88%	47,516 $2.71 Million
Q3 2017 Oct 26, 2017	BUY	$48.06 - $53.64 $1.9 Million - $2.13 Million	39,636	39,636 $2.12 Million

Others Institutions Holding ABT

# of Institutions

3,577

Shares Held

1.38B

Call Options Held

9.72M

Put Options Held

8.83M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $224B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dempze Nancy E, based on Form 13F filings with the SEC.

News

Stay updated on Dempze Nancy E with notifications on news.

Account